Indicadores pronósticos del síndrome coronario agudo sin elevación del segmento ST

Antman, 2001, Issues in early risk stratification for UA/NSEMI, Eur Heart J, 3, 6, 10.1016/S1520-765X(01)90135-X Bassan, 2001, Unidades de dolor torácico: estado actual del manejo de pacientes con dolor torácico en los servicios de urgencias, Rev Esp Cardiol, 54, 1103, 10.1016/S0300-8932(01)76457-3 Sanchis, 2002, Valor de la prueba de esfuerzo precoz en un protocolo de unidad de dolor torácico, Rev Esp Cardiol, 55, 1089, 10.1016/S0300-8932(02)76761-4 Kaul, 2001, Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb, J Am Coll Cardiol, 38, 64, 10.1016/S0735-1097(01)01307-9 Hamm, 2001, Cardiac biomarkers for rapid evaluation of chest pain, Circulation, 104, 1454, 10.1161/circ.104.13.1454 Sabatine, 2002, Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Simultaneous assessment of troponin I. C-reactive protein and B-type natriuretic pepetide, Circulation, 105, 1760, 10.1161/01.CIR.0000015464.18023.0A Lindahl, 2000, Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease, N Engl J Med, 343, 1139, 10.1056/NEJM200010193431602 Sonel, 2000, Prospective study correlating fibrinopeptide A troponin I myoglobin, and myosin light chain levels with early and late ischemic events in consecutive patients presenting to the emergency department with chest pain, Circulation, 102, 1107, 10.1161/01.CIR.102.10.1107 Bodí, 2002, Pronóstico a corto plazo de los pacientes ingresados por probable síndrome coronario agudo sin elevación del segmento ST. Papel de los nuevos marcadores de daño miocárdico y de los reactantes de fase aguda, Rev Esp Cardiol, 55, 823, 10.1016/S0300-8932(02)76711-0 1983, Risk stratification and survival after myocardial infarction, N Engl J Med, 309, 331, 10.1056/NEJM198308113090602 Braunwald, 2002, ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction, J Am Coll Cardiol, 40, 1366, 10.1016/S0735-1097(02)02336-7 Steg, 2002, Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE), Am J Cardiol, 90, 358, 10.1016/S0002-9149(02)02489-X Toss, 1997, Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable artery disease, Circulation, 96, 4204, 10.1161/01.CIR.96.12.4204 Bueno, 2002, Prevención y tratamiento de la cardiopatía isquémica en pacientes con diabetes mellitus, Rev Esp Cardiol, 55, 975, 10.1016/S0300-8932(02)76736-5 Alonso, 2002, Angioplastia coronaria en el paciente diabético. Situación actual y perspectivas futuras, Rev Esp Cardiol, 55, 1185, 10.1016/S0300-8932(02)76782-1 Goldman, 2001, Implications of troponin testing in clinical medicine, Curr Control Trials Cardiovasc Med, 2, 75, 10.1186/CVM-2-2-075 Bodí, 2002, ¿Es la troponina I útil para predecir el riesgo hospitalario en pacientes con angina inestable ingresados en un hospital comarcal? Resultados de un estudio prospectivo, Rev Esp Cardiol, 55, 100, 10.1016/S0300-8932(02)76568-8 Newby, 2001, Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin and troponin I (CHECKMATE) study, Circulation, 103, 1832, 10.1161/01.CIR.103.14.1832 De Lemos, 2002, The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes: results from the TIMI 11B and TACTICS-TIMI 18 studies, J Am Coll Cardiol, 40, 238, 10.1016/S0735-1097(02)01948-4 Sanchis, 2003, Usefulness of concomitant myoglobin and troponin elevation as biochemical marker of mortality in non-ST-segment elevation acute coronary syndromes, Am J Cardiol, 91, 13, 10.1016/S0002-9149(02)03244-7 Sanchis, 2002, Factores pronósticos en la angina inestable con cambios dinámicos del electrocardiograma. Valor del fibrinógeno, Rev Esp Cardiol, 55, 921, 10.1016/S0300-8932(02)76730-4 Bozkurt, 2002, Relation of plasma homocysteine levels to intracoronary thrombus in unstable angina pectoris and in non-Q-wave acute myocardial infarction, Am J Cardiol, 90, 413, 10.1016/S0002-9149(02)02500-6 Libby, 2001, Current concepts of the pathogenesis of the acute coronary syndromes, Circulation, 104, 365, 10.1161/01.CIR.104.3.365 Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135, 10.1161/hc0902.104353 Sanjuán, 1997, Respuesta inflamatoria en el infarto agudo de miocardio. Valores predictivos, Rev Esp Cardiol, 50, 561, 10.1016/S0300-8932(97)73264-0 Mueller, 2002, Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients, Circulation, 105, 1412, 10.1161/01.CIR.0000012625.02748.62 Ferreirós, 1999, Independent prognostic value of elevated C-reactive protein in unstable angina, Circulation, 100, 1958, 10.1161/01.CIR.100.19.1958 Buffon, 2002, Widespread coronary inflammation in unstable angina, N Engl J Med, 347, 5, 10.1056/NEJMoa012295 Schoenhagen, 2002, Plaque vulnerability, plaque rupture and acute coronary syndromes. Multi-focal manifestation of a systemic disease process, Circulation, 106, 760, 10.1161/01.CIR.0000025708.36290.05 Cusack, 2002, Systemic inflammation in unstable angina is the result of myocardial necrosis, J Am Coll Cardiol, 39, 1917, 10.1016/S0735-1097(02)01899-5 Bhatt, 2002, Need to test the arterial inflammation hypothesis, Circulation, 106, 136, 10.1161/01.CIR.0000021112.29409.A2 Kluft, 2002, Is C-reactive protein an additional, surrogate end-point for statin treatment?, Eur Heart J, 23, 761, 10.1053/euhj.2001.3124 Bertrand, 2002, Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, Eur Heart J, 23, 1809, 10.1053/euhj.2002.3385 Mosca, 2002, C-reactive protein: to screen or not to screen?, N Engl J Med, 347, 1615, 10.1056/NEJMe020127